Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease
Molecular Therapy
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626006854?dgcid=rss_sd_all
Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626006854?dgcid=rss_sd_all
“Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease.” Molecular Therapy.
@article{article90233,
title = {Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626006854?dgcid=rss_sd_all}
}